Validation of an HPLC Method for the Determination of Diclofenac Diethylamine and Three of Its Impurities in a Gel Pharmaceutical Form

被引:1
作者
El Kacemi, Mounir [1 ]
El Orche, Aimen [2 ]
Elhamdaoui, Omar [1 ]
Laouni, Amine [1 ]
Azougagh, Mohamed [3 ]
Karrouchi, Khalid [1 ]
Bouatia, Mustapha [1 ]
El Karbane, Miloud [1 ]
机构
[1] Univ Mohammed 5, Fac Med Pharm, Lab Chim Analyt Bromatol, Mpasse Souissi 10100, Rabat, Morocco
[2] Univ Sultan Moulay Slimane, Lab Organ & Analyt Chem, Campus Mghilla,BP 523, Beni Mellal 23000, Morocco
[3] Mohammed V Univ, Natl Grad Sch Arts & Crafts ENSAM, Biomed Engn & Pharmaceut Sci Grp Res, 6207 Av Forces Armees Royales, Rabat 10100, Morocco
关键词
INDICATING UPLC METHOD; SODIUM; CHLORZOXAZONE; DEGRADATION;
D O I
10.1093/jaoacint/qsad078
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Background: Monitoring impurities in drug products is a principal requirement of pharmaceutical regulatory authorities all over the world to ensure drug safety. For this reason, there is a great need for analytical QC of dugs products. Objective In this study, a simple, efficient, and direct HPLC method was developed for the determination of three impurities of diclofenac. Methods: The HPLC method was developed using a mobile phase which consisted of an HPLC grade mixture, acetonitrile-0.01M phosphoric acid adjusted to pH 2.3 (1 + 3, by volume). Results: The separation was performed in 15 min. The calibration curves of the three impurities were linear; the correlation coefficients were 0.999 at concentrations of 0.00015-0.003 mu g/mL. Conclusion: The validation of this method shows that it meets all validation criteria. This shows the reliability of this method for the routine control of diclofenac impurities. Highlights: The validation of a robust HPLC method for the determination of diclofenac impurities is of great importance for the pharmaceutical industry to control its products.
引用
收藏
页码:1443 / 1454
页数:12
相关论文
共 23 条
  • [1] Simultaneous analysis of chlorzoxazone, diclofenac sodium and tramadol hydrochloride in presence of three potential impurities using validated HPLC-DAD and HPTLC methods
    Ahmed, Hytham M.
    Elshamy, Yousef S.
    Talaat, Wael
    Labib, Hala F.
    Belal, Tarek S.
    [J]. MICROCHEMICAL JOURNAL, 2020, 153
  • [2] Assuring quality of drugs by monitoring impurities
    Ahuja, Satinder
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (01) : 3 - 11
  • [3] Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology
    Altman, Roy
    Bosch, Bill
    Brune, Kay
    Patrignani, Paola
    Young, Clarence
    [J]. DRUGS, 2015, 75 (08) : 859 - 877
  • [4] [Anonymous], 2019, European Pharmacopoeia, V10th
  • [5] [Anonymous], 1996, International Conference on Harmonization of Technical Requirements, for Registration of Pharmaceuticals for Human Use, ICH, Harmonized Tripartite Guideline for Good Clinical Practice E6(R1), Step 4 version
  • [6] [Anonymous], HARMONISED TRIPARTIT
  • [7] Azougagh M., 2016, Annales Pharmaceutiques Francaises, V74, P358, DOI 10.1016/j.pharma.2016.07.001
  • [8] Simultaneous Electrochemical Determination of Chlorzoxazone and Diclofenac on an Efficient Modified Glassy Carbon Electrode by Lanthanum Oxide@ Copper(I) Sulfide Composite
    Baniahmad, Bahar
    Nadiki, Hadi Hassani
    Jahani, Shohreh
    Nezamabadi-Pour, Najmeh
    Toolabi, Ali
    Foroughi, Mohammad Mehdi
    [J]. FRONTIERS IN CHEMISTRY, 2022, 10
  • [9] Dhaneshwar S.R., 2010, J ANAL BIOANAL TECH, V1, P109
  • [10] A validated stability-indicating UPLC method for determination of diclofenac sodium in its pure form and matrix formulations
    Elzayat, Ehab M.
    Ibrahim, Mohamed F.
    Abdel-Rahman, Ali A.
    Ahmed, Sayed M.
    Alanazi, Fars K.
    Habib, Walid A.
    [J]. ARABIAN JOURNAL OF CHEMISTRY, 2017, 10 : S3245 - S3254